Arexvy

Respiratory Synctial Virus (RSV): What you need to know

Who is eligible?

  • Routine vaccination: Patients age 75 years or older with no history of RSV vaccination.

  • For Risk based vaccination: Age 60 through 74 years with no history of RSV vaccination and meet criteria for being at increased risk of RSV based on one ore more conditions:

What is it for?

  • Arexvy is a vaccine indicated for active immunization for the prevention of lower respiratory tract disease (LRTD) caused by respiratory syncytial virus (RSV)

Where should I get it?

  • Schedule an appointment at your local Pharmacy Modern Drug!

Center for Biologics Evaluation and Research. (n.d.). Arexvy. U.S. Food and Drug Administration. https://www.fda.gov/vaccines-blood-biologics/arexvy

Administering respiratory syncytial virus vaccine (RSV) to ... (n.d.). https://www.immunize.org/wp-content/uploads/catg.d/p3098.pdf

Box of respiratory syncytial virus vaccine, for adults 60 years and older, showing product details and instructions.